NO20045304L - Fremgangsmate for regulert hyperstimulering av eggstokk, samt kitt for anvendelse i samme - Google Patents

Fremgangsmate for regulert hyperstimulering av eggstokk, samt kitt for anvendelse i samme

Info

Publication number
NO20045304L
NO20045304L NO20045304A NO20045304A NO20045304L NO 20045304 L NO20045304 L NO 20045304L NO 20045304 A NO20045304 A NO 20045304A NO 20045304 A NO20045304 A NO 20045304A NO 20045304 L NO20045304 L NO 20045304L
Authority
NO
Norway
Prior art keywords
substance
administration
fsh
amount equivalent
unit containing
Prior art date
Application number
NO20045304A
Other languages
English (en)
Norwegian (no)
Inventor
Herman Jan Tijmen Coel Bennink
Evert Johannes Bunschoten
Original Assignee
Ares Trading Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ares Trading Sa filed Critical Ares Trading Sa
Publication of NO20045304L publication Critical patent/NO20045304L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Pregnancy & Childbirth (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20045304A 2002-06-07 2004-12-03 Fremgangsmate for regulert hyperstimulering av eggstokk, samt kitt for anvendelse i samme NO20045304L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02077221 2002-06-07
PCT/NL2003/000370 WO2003103770A2 (en) 2002-06-07 2003-06-06 Method of controlled ovarian hyperstimulation and pharmaceutical kit for use in such method

Publications (1)

Publication Number Publication Date
NO20045304L true NO20045304L (no) 2005-02-07

Family

ID=29724462

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20045304A NO20045304L (no) 2002-06-07 2004-12-03 Fremgangsmate for regulert hyperstimulering av eggstokk, samt kitt for anvendelse i samme

Country Status (21)

Country Link
US (1) US7815912B2 (de)
EP (1) EP1511537B1 (de)
JP (1) JP2005530818A (de)
KR (1) KR20050058285A (de)
CN (1) CN1684737A (de)
AU (1) AU2003274929B2 (de)
BR (1) BR0305033A (de)
CA (1) CA2488719A1 (de)
EA (1) EA009371B1 (de)
ES (1) ES2399962T3 (de)
IL (1) IL165522A0 (de)
IS (1) IS7586A (de)
ME (1) MEP39308A (de)
MX (1) MXPA04012246A (de)
NO (1) NO20045304L (de)
NZ (1) NZ536984A (de)
PL (1) PL373991A1 (de)
RS (1) RS105004A (de)
UA (1) UA81251C2 (de)
WO (1) WO2003103770A2 (de)
ZA (1) ZA200409857B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602008001783D1 (de) * 2007-01-08 2010-08-26 Pantarhei Bioscience Bv Verfahren zur behandlung oder prävention von unfruchtbarkeit bei weiblichen säugern und pharmazeutisches kit zur anwendung dieses verfahrens
AU2012286048A1 (en) * 2011-07-18 2014-02-20 Arts Biologics A/S Long acting luteinizing hormone (LH) compound
US20150272622A1 (en) 2011-12-22 2015-10-01 Previvo Genetics, Llc Recovery and processing of human embryos formed in vivo
US9282995B2 (en) * 2011-12-22 2016-03-15 Previvo Genetics, Llc Recovery and processing of human embryos formed in vivo
US9216037B2 (en) 2013-06-21 2015-12-22 Previvo Genetics, Llc Uterine lavage for embryo retrieval
WO2018015497A2 (en) 2016-07-21 2018-01-25 ObsEva S.A. Oxytocin antagonist dosing regimens for promoting embryo implantation and preventing miscarriage
US20220323410A1 (en) 2019-09-03 2022-10-13 ObsEva S.A. Oxytocin antagonist dosing regimens for promoting embryo implantation and preventing miscarriage
CN115380122A (zh) 2020-02-10 2022-11-22 奥布赛瓦股份公司 用于催产素受体拮抗剂疗法的生物标志物
WO2026018221A1 (en) 2024-07-18 2026-01-22 ReproNovo SA Crystalline compositions for improving embryo implantation and methods of using the same

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0788799A3 (de) 1996-02-07 1998-10-21 ASTA Medica Aktiengesellschaft LHRH-Antagoniste für Behandlung von Fruchtbarkeitsstörungen
CN1199642A (zh) * 1997-05-16 1998-11-25 Asta药物股份公司 治疗不育症的lhrh－拮抗剂
AU8727798A (en) 1997-06-20 1999-01-04 Akzo Nobel N.V. Gonadotropin releasing hormone antagonist
ATE252910T1 (de) 1998-04-23 2003-11-15 Zentaris Ag Methode zur behandlung von fruchtbarkeitsstörungen
AU2794100A (en) * 1999-02-24 2000-09-14 Novo Nordisk A/S Treatment of infertility
WO2001000227A1 (en) 1999-06-23 2001-01-04 Akzo Nobel N.V. Gonadotropin releasing hormone antagonist
US20030092628A1 (en) * 1999-06-23 2003-05-15 De Greef Henrik Johan Matthieu Maria Gonadotropin releasing hormone antagonist
SI1434600T1 (sl) * 2001-09-12 2009-06-30 Serono Lab Uporaba lh za kontrolirano hiperstimulacijo ovarijev
EP1862182A2 (de) 2001-12-21 2007-12-05 Pantarhei Bioscience B.V. Verfahren zur kontrollierten ovariellen Überstimulation und pharmazeutisches Kit zur Verwendung für dieses Verfahren

Also Published As

Publication number Publication date
UA81251C2 (en) 2007-12-25
WO2003103770A3 (en) 2004-04-22
CA2488719A1 (en) 2003-12-18
EP1511537A2 (de) 2005-03-09
RS105004A (sr) 2007-02-05
CN1684737A (zh) 2005-10-19
IS7586A (is) 2004-12-03
US7815912B2 (en) 2010-10-19
AU2003274929B2 (en) 2008-04-10
PL373991A1 (en) 2005-09-19
MEP39308A (en) 2011-02-10
ZA200409857B (en) 2006-02-22
EA200401619A1 (ru) 2005-06-30
EP1511537B1 (de) 2012-11-21
US20050235374A1 (en) 2005-10-20
EA009371B1 (ru) 2007-12-28
MXPA04012246A (es) 2005-04-08
JP2005530818A (ja) 2005-10-13
BR0305033A (pt) 2004-11-09
KR20050058285A (ko) 2005-06-16
NZ536984A (en) 2008-01-31
WO2003103770A2 (en) 2003-12-18
IL165522A0 (en) 2006-01-15
AU2003274929A1 (en) 2003-12-22
ES2399962T3 (es) 2013-04-04

Similar Documents

Publication Publication Date Title
Pierroz et al. Chronic administration of neuropeptide Y into the lateral ventricle starting at 30 days of life delays sexual maturation in the female rat
Schally et al. LH‐RH agonists and antagonists
Ayalon et al. Acute Effect of▵ 1–Tetrahydrocannabinol on the Hypothalamo-Pituitary-Ovarian Axis in the Rat
Lin et al. Effects of [d-Arg6, Trp7, Leu8, Pro9 NEt]-luteinizing hormone-releasing hormone (sGnRH-A) and [d-Ala6, Pro9NEt]-luteinizing hormone-releasing hormone (LHRH-A), in combination with pimozide or domperidone, on Gonadotropin release and ovulation in the Chinese loach and common carp
ITMI941048A1 (it) Uso di antagonisti degli oppiacei e di sali di calcio per la preparazione di medicamenti per il trattamento di forme patologiche endorfino-mediate
AU2002310788B2 (en) Treatment of dementia and neurodegenerative diseases with intermediate doses of LHRH antagonists
Sahu et al. Dynamic changes in neuropeptide Y concentrations in the median eminence in association with preovulatory luteinizing hormone release in the rat
DE69927705T2 (de) Verwendung von acetylcholinesterase inhibitoren zur modulierung der hypothalamus-hypophysen-gonadenachse
Buckingham et al. Effects of naloxone on hypothalamo-pituitary-adrenocortical activity in the rat
EA001178B1 (ru) Применение lhrh-аналога или комбинации lhrh-аналогов и антиэстрогена с селективным по отношению к тканям эстрогенным действием для лечения гинекологических нарушений
Corbin et al. Peptide Contraception: Antifertility Properties of LH‐RH Analogues
Neidhart Bromocriptine has little direct effect on murine lymphocytes, the immunomodulatory effect being mediated by the suppression of prolactin secretion
EA200401619A1 (ru) Способ управляемой гиперстимуляции яичников и фармацевтический набор для использования в таком способе
RU2181598C2 (ru) Восстановление тонической секреции эстрогена из яичников для продолжительных схем лечения
PT1425033E (pt) Utilização de hcg e lh na hiper-estimulação controlada dos ovários
Loutradis et al. A modified gonadotropin-releasing hormone (GnRH) antagonist protocol failed to increase clinical pregnancy rates in comparison with the long GnRH protocol
US20210137923A1 (en) Treatment of sexual dysfunction
Grossman Opioid peptides and reproductive function
ADELSON et al. Effects of gonadotropin-releasing hormone analogues on ovarian epithelial tumors
CA2472309A1 (en) Multiple dose aromatase inhibitor for treating infertility
YU81203A (sh) Pojedinačna doza inhibitora aromataze za lečenje neplodnosti
KR20030051828A (ko) 에스트로겐 의존성 질환의 병용 치료법
Omi et al. Evidence that systemic relaxin promotes moderate water consumption during late pregnancy in rats
JP2004529924A5 (de)
van Wimersma Greidanus et al. to the Role of Opioid Peptides¹

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application